Posted in | News | Gold | Mining Business

Quinto, TomaGold Amend their Agreement for Monster Lake Property

TomaGold Corporation (“TomaGold” or the “Company”) and Quinto Real Capital Corporation (“Quinto”) have agreed to contractually amend their agreement dated November 26, 2012, for the Monster Lake property (“Monster Lake”), located near Quebec’s Chibougamau mining camp.

To be finalized in the coming weeks, the new agreement essentially provides for:

  • The agreement dated November 26, 2012, to be cancelled;
  • TomaGold to henceforth hold an 85% interest in Monster Lake and be the sole project operator; and
  • Quinto to own a 15% interest in Monster Lake.

David Grondin, President and CEO of TomaGold, stated that: “This new agreement is very positive for both parties because it optimizes the development of the Monster Lake project. TomaGold becomes the sole operator of the project and continues to consolidate its dominant position around Monster Lake, and Quinto retains a 15% interest in a high-value project with growing potential. In the coming weeks, we will devote our efforts to the launch of our next drilling program at Monster Lake.”

The transaction is subject to the approval of the TSX Venture Exchange and the signature of a final agreement by the parties.

The Company has also granted 300,000 stock options to certain directors pursuant to the Company’s stock option plan. The options are exercisable over a five year period at an exercise price of $0.20 per share.

About TomaGold Corporation
TomaGold Corporation is a Canadian-based mining exploration company whose primary mission is the acquisition, exploration and development of gold projects in Canada and abroad.

Source: http://www.hrw.net

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.